Cyclooxygenase-2 expression and oxidative DNA adducts in murine intestinal adenomas: Modification by dietary curcumin and implications for clinical trials

European Journal of Cancer

Volumn 42, Issue 3, 2006, Pages 415-421

  Tunstall, R G ^a   Sharma, R A ^a,b   Perkins, S ^a   Sale, S ^a   Singh, R ^a   Farmer, P B ^a   Steward, W P ^a   Gescher, A J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Chemoprevention; Colorectal carcinogenesis; DNA damage

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; APC PROTEIN; BIOLOGICAL MARKER; CURCUMIN; CYCLOOXYGENASE 2; DEOXYGUANOSINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER STAGING; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA ADDUCT; DRUG RESPONSE; HISTOPATHOLOGY; IMMUNOCHEMISTRY; INTESTINE POLYP; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; WESTERN BLOTTING;

ADENOMATOUS POLYPOSIS COLI; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CURCUMIN; CYCLOOXYGENASE 2; DNA ADDUCTS; MICE; MICE, INBRED C57BL;

EID: 31144441094     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.10.024     Document Type: Article

References (39)

1. C.V. Rao, A. Rivenson, and B. Simi Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound Cancer Res 55 1995 259 266
2. G.J. Kelloff, J.A. Crowell, and E.T. Hawk Strategy and planning for chemopreventive drug development: clinical development plans II J Cell Biochem 63 26S 1996 54 71
3. T. Kawamori, R. Lubet, and V.E. Steele Chemopreventative effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer Cancer Res 59 1999 597 601
4. N.N. Mahmoud, A.M. Carothers, and D. Grunberger Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis Carcinogenesis 21 2000 921 927
5. S. Perkins, R.D. Verschoyle, and K.A. Hill Chemopreventive efficacy and pharmacokinetics of curcumin in the Min/+ mouse, a model of familial adenomatous polyposis Cancer Epidemiol Biomarkers Prev 11 2002 535 540
6. B. Vogelstein, E.R. Fearon, and S.R. Hamilton Genetic alterations during colorectal-tumor development N Engl J Med 319 1988 525 532
7. R.A. Sharma, A.J. Gescher, and W.P. Steward Curcumin: The story so far Eur J Cancer 41 2005 1955 1968
8. R.A. Sharma, S.A. Euden, and S.L. Platton Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance Clin Cancer Res 10 2004 6847 6854
9. G. Garcea, D.P. Berry, and D.J.L. Jones Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences Cancer Epidemiol Biomarkers Prev 14 2005 120 125
10. A.L. Cheng, C.H. Hsu, and J.K. Lin Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions Anticancer Res 21 2001 2895 2900
11. C. Ireson, S. Orr, and D.J.L. Jones Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production Cancer Res 61 2001 1058 1064
12. S.M. Plummer, K.A. Holloway, and M.M. Manson Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex Oncogene 18 1999 6013 6020
13. S.V. Jovanovic, S. Steenken, and C.W. Boone H-atom transfer is a preferred antioxidant mechanism of curcumin J Am Chem Soc 121 1998 9677 9681
14. R.A. Sharma, C.R. Ireson, and R.D. Verschoyle Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels Clin Cancer Res 7 2001 1452 1458
15. L.J. Marnett Oxyradicals and DNA damage Carcinogenesis 21 2000 361 370
16. R.A. Sharma, A. Gescher, and J.P. Plastaras Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells Carcinogenesis 9 2001 1557 1560
17. M.Y. Wang, K. Dhingra, and W.N. Hittleman Lipid peroxidation induced putative malondialdehyde-DNA adducts in human breast tissues Cancer Epidemiol Biomarkers Prev 5 1996 705 710
18. P.C. Dedon, J.P. Plastaras, and C.A. Rouzer Indirect mutagenesis by oxidative DNA damage: formation of the pyrimidopurinone adduct of deoxyguanosine by base propenal Proc Natl Acad Sci USA 95 1998 11113 11116
19. D.I. Feig, L.C. Sowers, and L.A. Loeb Reverse chemical mutagenesis: identification of the mutagenic lesions resulting from reactive oxygen species-mediated damage to DNA Proc Natl Acad Sci USA 91 1994 6609 6613
20. K.C. Cheng, D.S. Cahill, and H. Kasai 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G → T and A → C substitutions J Biol Chem 267 1992 166 172
21. Y. Nakamura, R. White, and A.M. Smits Genetic alterations during colorectal-tumor development N Engl J Med 319 1988 525 532
22. S. Singh, and B.B. Aggarwal Activation of transcription factor NF-kappaB is suppressed by curcumin (diferulolylmethane) J Biol Chem 270 1995 24995 25000
23. S.M. Plummer, K.A. Hill, and M.F.W. Festing Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents Cancer Epidemiol Biomarkers Prev 10 2001 1295 1299
24. H. Bamba, S. Ota, and A. Kato High expression of cyclooygenase-2 in macrophages of human colonic adenoma Int J Cancer 83 1999 470 475
25. M.A. Hull, J.K. Booth, and A. Tisbury Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice Br J Cancer 79 1999 1399 1405
26. F.A. Sinicrope, M. Lemoine, and L. Xi Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers Gastroenterology 117 1999 350 358
27. R.F. Jacoby, K. Seibert, and C.E. Cole The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis Cancer Res 60 2000 5040 5044
28. P. Workman, P. Twentyman, and F. Balkwill United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (2nd ed.) Br J Cancer 77 1998 1 10
29. C. Luongo, A.R. Moser, and S. Gledhill Loss of Apc (+) in intestinal adenomas from Min mice Cancer Res 54 1994 5947 5952
30. C. Leuratti, R. Singh, and C. Lagneau Determination of malondialdehyde-induced DNA damage in human tissues using an immunoslot blot assay Carcinogenesis 19 1998 1919 1924
31. R. Singh, M. McEwan, and J.H. Lamb An improved liquid chromatography-mass spectrometry/mass spectrometry method for the determination of 8-hydroxy-2′-deoxyguanosine in DNA samples using immunoaffinity column purification Rapid Commun Mass Spec 17 2003 126 134
32. H. Takeda, M. Sonoshita, and H. Oshima Cooperation of cyclooxygenase 1 and cyclooxygenase 2 in intestinal polyposis Cancer Res 63 2003 4872 4877
33. Δ716 mouse intestinal polyps Cancer Res 62 2002 506 511
34. G. Steinbach, P.M. Lynch, and R.K.S. Phillips The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis N Engl J Med 342 2000 1946 1952
35. S.K. Boolbol, A.J. Dannenberg, and A. Chadburn Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis Cancer Res 56 1996 2556 2560
36. F.M. Giardiello, S.R. Hamilton, and A.J. Krush Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis N Engl J Med 328 1993 1313 1316
37. C. Leuratti, M.A. Watson, and E.J. Deag Detection of malondialdehyde-DNA adducts in human colorectal mucosa: relationship with diet and the presence of adenomas Cancer Epidemiol Biomarkers Prev 11 2002 267 273
38. C.E. Eberhart, R.J. Coffey, and A. Radhika Upregulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1994 1183 1188
39. K. Uefuji, T. Ichikura, and H. Mochizuki Expression of cyclooxygenase-2 in human gastric adenomas and adenocarcinomas J Surg Oncol 76 2001 26 30